DOCSLIB.ORG

Primary Splenic Histiocytic Sarcoma Complicated with Prolonged

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Primary Splenic Histiocytic Sarcoma Complicated with Prolonged Yamada et al. Diagnostic Pathology 2012, 7:143 http://www.diagnosticpathology.org/content/7/1/143 CASE REPORT Open Access Primary splenic histiocytic sarcoma complicated with prolonged idiopathic thrombocytopenia and secondary bone marrow involvement: a unique surgical case presenting with splenomegaly but non-nodular lesions Sohsuke Yamada1*, Takashi Tasaki11, Naoko Satoh1,2, Atsunori Nabeshima1, Shohei Kitada1,3, Hirotsugu Noguchi1, Kozue Yamada4, Morishige Takeshita4 and Yasuyuki Sasaguri1 Abstract: A 67-year-old Japanese female was followed up due to prolonged idiopathic thrombocytopenia with non-response to steroid therapy for 4 years, but recent progressive pancytopenia, hypo-albuminemia, and hypo-γ-globulinemia were presented. An abdominal CT scan revealed heterogeneously enhanced splenomegaly without any nodular lesions. A splenectomy was performed, and gross examination showed markedly hyperemic red pulp, weighing 760 g, accompanied by multiple foci of peripheral anemic infarction. Surprisingly, microscopic findings exhibited a diffuse proliferation of medium-sized to large tumor cells having pleomorphic nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm, predominantly within the sinuses and cords of the red pulp, which occasionally displayed conspicuous hemophagocytosis and vascular permeation. In immunohistochemistry, these atypical cells were specifically positive for CD68 (KP-1), CD163, and lysozyme, which was consistent with histiocytic sarcoma (HS) of the spleen. Subsequently, section from the aspiration of bone marrow showed infiltration of the neoplastic cells associated with erythrophagocytosis 2 months after the operation, but never before it. Therefore, primary splenic HS presenting with secondary bone marrow involvement was conclusively diagnosed. Since early diagnosis and treatment are necessary for the HS patients with poor outcomes, splenic HS should be considered as a differential diagnosis in cases with chronic thrombocytopenia and splenomegaly. Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/ vs/1009474924812827 Keywords: Thrombocytopenia, Spleen, Splenomegaly, Histocytic sarcoma (HS), Hemophagocytosis Background node, or soft tissues [1-3], however, primary HS of the By definition, histiocytic sarcoma (HS), a rare spleen has been an exceedingly rare. Mathé G et al. first hematopoietic neoplasm, but a known entity, represent- proposed the term ‘HS’ tentatively in 1970 [4]. In con- ing as less than 0.5% of all non-Hodgkin’s lymphoma, is trast, since its description was strictly based on the malignant proliferation of cells presenting morphologic histologic similarities of the tumor cells to macrophages, and immunophenotypic characteristics of mature tissue this diagnostic challenge is further complicated as it is histiocytes [1,2]. HS is known to often present as loca- critical to clearly distinguish HS from other histiocytic lized disease confined to the intestinal tract, skin, lymph processes, from benign to malignant, such as hemopha- gocytic syndrome, malignant histiocytosis, and acute * Correspondence: [email protected] monocytic leukemia [5-7]. Despite that, the detailed 1Department of Pathology and Cell Biology, School of Medicine, University of evaluation of HS depends especially on the verification Occupational and Environmental Health, Kitakyushu 807-8555, Japan Full list of author information is available at the end of the article of histiocytic lineage and the exclusion of other © 2012 Yamada et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Yamada et al. Diagnostic Pathology 2012, 7:143 Page 2 of 7 http://www.diagnosticpathology.org/content/7/1/143 malignancies, including anaplastic large cell lymphoma, immunohistochemical examinations. All immunohisto- diffuse large B-cell lymphoma, poorly differentiated car- chemical stainings were carried out using Dako Envision cinoma, malignant melanoma, follicular dendritic cell kit (Dako Cytomation Co., Glostrup, Denmark) accord- sarcoma, or interdigitating dendritic cell sarcoma, by ing to the manufacturer’s instructions, and using com- way of thorough immunohistochemical examination [1- mercially available prediluted monoclonal antibodies 3,8,9]. In this context, it is very difficult to interpret HS against the following antigens: CD1a (Immuno Tech. papers published more than 25 years ago, i.e., before the Co., Ltd., Osaka, Japan, diluted 1:2), CD3 (Dako, diluted development and widespread use of immunohistochem- 1:1), CD4 (Dako, diluted 1:1), CD5 (NOVOCASTRA la- ical techniques and the availability of molecular genetic boratories Ltd., Newcastle, United Kingdom, diluted tools [3]. Actually, until now, the number of ‘true’ cases 1:25), CD8 (Nichirei Biosciences Inc., Tokyo, Japan, reported as primary splenic HS in the English literatures diluted 1:1), CD10 (NOVOCASTRA, diluted 1:20), is only few, up to 7, and most recent references are from CD20 (Dako, diluted 1:200), CD21 (Dako, diluted 1:10), 2008 within our investigation [10-14], summarized in CD23 (Nichirei, diluted 1:1), CD30 (Dako, diluted 1:40), Table 1, and its clinicopathological features have not CD45 (Dako, diluted 1:400), CD45RO (UCHL-1; Dako, been well described. Based on this Table 1, HS of the diluted 1:200), CD68 (KP-1; Dako, diluted 1:100), CD79a spleen can be potentially lethal condition that might re- (Dako, diluted 1:50), CD163 (Leica Microsystems, Wet- main asymptomatic or closely related with chronic zlar, Germany, diluted 1:200), lysozyme (Dako, diluted thrombocytopenia for a long time [11-13]. Even while 1:600), S-100 protein (Dako, diluted 1:900), fascin (Dako, diagnostic imaging findings have not been also charac- diluted 1:50), bcl-2 (Dako, diluted 1:30), myeloperoxi- terized satisfactorily, primary splenic HS cases often dase (MPO; Dako, dilutede 1:500), EMA (Dako, diluted show multi-nodular or nodular lesions in the enlarged 1:100), Cam5.2 (Becton Dickinson Immunocytometry tissues of spleen [10-14]. The patients of splenic HS have Systems, San Jose, CA, diluted 1:1), and HMB45 (Enzo a poor prognosis due to aggressive behavior with liver or Life Sciences Ltd., New York, diluted 1:100). Epstein- bone marrow infiltration, even though a splenectomy Barr virus (EBV) infection status was analyzed by in situ might induce temporary remission [11,14]. Therefore, hybridization for EBV-encoded RNAs using an Epstein- early accurate diagnosis and treatment before dissemi- Barr Early RNA Probe Reagent (EBER; Roche Applied nated proliferation of the HS tumor cells should improve Science, Lewes, UK). However, no chromosome studies their survival rates. have been performed. Indeed, this is not the first case reported. Despite that, we reported a very rare and unique surgical case Case presentation of primary splenic HS complicated with prolonged This patient had 4-year-history of idiopathic idiopathic thrombocytopenia, progressive pancytopenia, thrombocytopenia with non-response to steroid therapy hypo-albuminemia, hypo-γ-globulinemia, and secondary and progressive pancytopenia half year before a splenec- bone marrow involvement, which grossly presented as tomy (Figure 1A). There was no history of immunosup- splenomegaly with multiple peripheral infarction but pressive disorders, use of immunosuppressive medications, without any nodular foci. or unusual infections. The abdominal CT scanning showed heterogeneously enhanced and growing spleno- Materials and methods megaly without evidence of mass or nodular lesions, The patient was a 67-year-old Japanese female. The spe- measured approximately 130 × 80 mm in diameter cimen after fixation in 10% neutral buffered formalin (Figure 1B). Retrospectively, the clinical imaging examin- was embedded in paraffin for histological or ation also demonstrated mild splenomegaly, measured Table 1 Comparison of the main clinical features among the reported cases with primary splenic HS, including ours Case [reference] Age Sex CC Imaging or Gross features Weight of spleen Therapy Prognosis Involvement 1[10] 38 m Weakness multinodular 264 g S - - 2[11] 29 m edema nodular 735 g S(R+C) 5Y1M Liver 3[11] 60 m thrombocytopenia nodular 610 g S+C 1Y6M Liver, BM 4[11] 66 f edema, anemia multinodlar 750 g R+S+C 2Y6M Liver, BM 5[12] 71 f thrombocytopenia multinodlar 470 g C 6 M Hilum LN 6[13] 82 f Evans syn, multinodular 110 g R 1 M Liver 7[14] 58 f anemia nodular 800 g R+S+C 3 M - Present case 67 thrombocytopenia non-nodula 760 g S 6 M BM CC chief complaint, S surgery (splenectomy), R radiation, C chemotherapy, Y year, M month, BM bone marrow, LN lymph node. Yamada et al. Diagnostic Pathology 2012, 7:143 Page 3 of 7 http://www.diagnosticpathology.org/content/7/1/143 Figure 1 Summary of various clinical data before and after splenectomy, and the finding of an abdominal CT scan at surgery. (A) This patient showed prolonged idiopathic thrombocytopenia presenting with increased splenomegaly and non-response to steroid therapy. In addition, progressive pancytopenia, hypo-albuminemia, and hypo-γ-globulinemia coexisted. (B) The abdominal CT scanning revealed heterogeneously enhanced, severe splenomegaly without evidence of mass or nodular lesions. 48 × 39 mm or 95 × 34 mm in diameter 3 or 2 years proliferation of atypical
Load more

Recommended publications
  • Human Anatomy As Related to Tumor Formation Book Four
    SEER Program Self Instructional Manual for Cancer Registrars Human Anatomy as Related to Tumor Formation Book Four Second Edition U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutesof Health SEER PROGRAM SELF-INSTRUCTIONAL MANUAL FOR CANCER REGISTRARS Book 4 - Human Anatomy as Related to Tumor Formation Second Edition Prepared by: SEER Program Cancer Statistics Branch National Cancer Institute Editor in Chief: Evelyn M. Shambaugh, M.A., CTR Cancer Statistics Branch National Cancer Institute Assisted by Self-Instructional Manual Committee: Dr. Robert F. Ryan, Emeritus Professor of Surgery Tulane University School of Medicine New Orleans, Louisiana Mildred A. Weiss Los Angeles, California Mary A. Kruse Bethesda, Maryland Jean Cicero, ART, CTR Health Data Systems Professional Services Riverdale, Maryland Pat Kenny Medical Illustrator for Division of Research Services National Institutes of Health CONTENTS BOOK 4: HUMAN ANATOMY AS RELATED TO TUMOR FORMATION Page Section A--Objectives and Content of Book 4 ............................... 1 Section B--Terms Used to Indicate Body Location and Position .................. 5 Section C--The Integumentary System ..................................... 19 Section D--The Lymphatic System ....................................... 51 Section E--The Cardiovascular System ..................................... 97 Section F--The Respiratory System ....................................... 129 Section G--The Digestive System ......................................... 163 Section
    [Show full text]
  • Histiocytic and Dendritic Cell Lesions
    1/18/2019 Histiocytic and Dendritic Cell Lesions L. Jeffrey Medeiros, MD MD Anderson Cancer Center Outline 2016 classification of Histiocyte Society Langerhans cell histiocytosis / sarcoma Erdheim-Chester disease Juvenile xanthogranuloma Malignant histiocytosis Histiocytic sarcoma Interdigitating dendritic cell sarcoma Follicular dendritic cell sarcoma Rosai-Dorfman disease Hemophagocytic lymphohistiocytosis Writing Group of the Histiocyte Society 1 1/18/2019 Major Groups of Histiocytic Lesions Group Name L Langerhans-related C Cutaneous and mucocutaneous M Malignant histiocytosis R Rosai-Dorfman disease H Hemophagocytic lymphohistiocytosis Blood 127: 2672, 2016 L Group Langerhans cell histiocytosis Indeterminate cell tumor Erdheim-Chester disease S100 Normal Langerhans cells Langerhans Cell Histiocytosis “Old” Terminology Eosinophilic granuloma Single lesion of bone, LN, or skin Hand-Schuller-Christian disease Lytic lesions of skull, exopthalmos, and diabetes insipidus Sidney Farber Letterer-Siwe disease 1903-1973 Widespread visceral disease involving liver, spleen, bone marrow, and other sites Histiocytosis X Umbrella term proposed by Sidney Farber and then Lichtenstein in 1953 Louis Lichtenstein 1906-1977 2 1/18/2019 Langerhans Cell Histiocytosis Incidence and Disease Distribution Incidence Children: 5-9 x 106 Adults: 1 x 106 Sites of Disease Poor Prognosis Bones 80% Skin 30% Liver Pituitary gland 25% Spleen Liver 15% Bone marrow Spleen 15% Bone Marrow 15% High-risk organs Lymph nodes 10% CNS <5% Blood 127: 2672, 2016 N Engl J Med
    [Show full text]
  • Malignant Histiocytosis in a Cat – Case Report
    Trost et al; Malignant histiocytosis in a cat - Case report. Braz J Vet Pathol; 2008, 1(1): 32 - 35 32 Case Report Malignant histiocytosis in a cat – Case report Maria E. Trost 1, Adriano T. Ramos 1, Eduardo K. Masuda 1, Bruno L. dos Anjos 1, Marina G. M. C. M. Cunha 2, Dominguita L. Graça 3* 1Laboratory of Veterinary Pathology, Federal University of Santa Maria (UFSM), RS, Brazil. 2Laboratory of Veterinary Surgery, Federal University of Santa Maria (UFSM), RS, Brazil. 3Department of Pathology, Federal University of Santa Maria (UFSM), RS, Brazil. *Corresponding author: Dominguita L. Graça, Department of Pathology, Science Health Center, UFSM, 97105-900, Santa Maria, RS, Brazil. Email: [email protected]. Submitted December 13th 2007, Accepted March 3rd 2008 Abstract A crossbred 14-year-old castrated male cat had a history of lethargy, anorexia and weight loss of one month evolution. On clinical examination, anemia, emaciation, jaundice and a large mass in the abdomen were detected. Ultrasonography revealed hepatomegaly and a single splenic mass. The cat was submitted to biopsy and euthanatized during the surgical procedure. The diagnosis of malignant histiocytosis was achieved on the basis of the clinical presentation, histopathologic and immunoistochemical findings. Key Words: Malignant histiocytosis, histiocytic diseases, neoplasia, pathology, diseases of cats Introduction in the literature (8); It affects individuals of several ages, with no sex or breed predisposition. The most affected Histiocytic neoplasms are a group of diseases organs are the spleen, liver, lung and bone marrow. Cats classified accordingly to local and biological behavior. with MH are anorexic, emaciated, lethargic, with fever and Focal and self-limiting lesions (cutaneous histiocytoma), dyspnea in a few cases.
    [Show full text]
  • Non-EBV-Related Aggressive NK-Cell Leukemia: an Oncohematological Great Imitator
    Case Report J Hematol. 2018;7(4):163-166 Non-EBV-Related Aggressive NK-Cell Leukemia: An Oncohematological Great Imitator Jose L. Lepe-Zunigaa, b, f, Francisco Javier Jeronimo-Lopeza, c, Jorge Gregorio Hernandez-Orantesa, d, Adriana Osiris Mendez-Cigarroaa, e Abstract Introduction Aggressive natural killer (NK)-cell leukemia (ANKL) is a very rare Ever since the expression “great imitator” was coined to re- oncohematological disease among youngsters in Latin America. Its fer to syphilis [1] and later to tuberculosis [2], the term has clinical picture imitates a variety of syndromes and diseases due to its been applied to several diseases that mimic others, making the pathophysiology. Its diagnosis is relatively simple due to the promi- real diagnosis more difficult. Pituitary apoplexy [3], cardiac nence of NK malignant cells in peripheral blood and its clinical ag- myxoma [4], lyme disease [5] and infectious mononucleosis gressiveness. In certain circumstances though, the presence of blast [6] have been so considered. In more recent times, the pre- NK cells and the natural course of the disease can be so modified by ferred great imitator has been lupus, because its clinical picture the treatment of one of the imitated diseases, especially when using can vary from predominantly hematological, to renal, hepatic, steroids, that it becomes very difficult to diagnose early in its course. neurological or dermatological in nature, challenging the cli- We present a case of a 16-year-old Mexican male who initiated symp- nician before the disease
    [Show full text]
  • Malignant Histiocytosis and Encephalomyeloradiculopathy
    Gut: first published as 10.1136/gut.24.5.441 on 1 May 1983. Downloaded from Gut, 1983, 24, 441-447 Case report Malignant histiocytosis and encephalomyeloradiculopathy complicating coeliac disease M CAMILLERI, T KRAUSZ, P D LEWIS, H J F HODGSON, C A PALLIS, AND V S CHADWICK From the Departments ofMedicine and Histopathology, Royal Postgraduate Medical School, Hammersmith Hospital, London SUMMARY A 62 year old Irish woman with an eight year history of probable coeliac disease developed brain stem signs, unilateral facial numbness and weakness, wasting and anaesthesia in both lower limbs. Over the next two years, a progressive deterioration in neurological function and in intestinal absorption, and the development of anaemia led to a suspicion of malignancy. Bone marrow biopsy revealed malignant histiocytosis. Treatment with cytotoxic drugs led to a transient, marked improvement in intestinal structure and function, and in power of the lower limbs. Relapse was associated with bone marrow failure, resulting in overwhelming infection. Post mortem examination confirmed the presence of an unusual demyelinating encephalomyelopathy affecting the brain stem and the posterior columns of the spinal cord. http://gut.bmj.com/ Various neurological complications have been patients with coeliac disease by Cooke and Smith.6 described in patients with coeliac disease. These She later developed malignant histiocytosis with include: peripheral neuropathy, myopathy, evidence of involvement of bone marrow. myelopathy, cerebellar syndrome, and encephalo- on September 27, 2021 by guest. Protected copyright. myeloradiculopathy.1 2 On occasion, neurological Case report symptoms may be related to a deficiency of water soluble vitamins or to metabolic complication of A 54 year old Irish woman first presented to her malabsorption, such as osteomalacia.
    [Show full text]
  • Immune Thrombocytopenic Purpura As Sole Manifestation And
    Case Report / Olgu Sunumu DOI: 10.5578/ced.57487 • (J Pediatr Inf 2017; 11: i35-i38) Immune Thrombocytopenic Purpura As Sole Manifestation and Hemophagocytic Lypmhohistiocytosis As Sole Manifestation of Hepatitis a Virus Infection in Two Children* İmmün Trombositopenik Purpuranın Tek Bulgu Olduğu ve Hemofagositik Lenfohistiositozun Tek Bulgu Olduğu İki Çocuk Olguda Hepatit A Virüs Enfeksiyonu Zümrüt Şahbudak Bal1, Semra Şen1, Nihal Karadaş Özdemir2, Katibe Başak Yıldız1, Deniz Yılmaz Karapınar2, Fadıl Vardar1 1 Department of Pediatric Infectious Diseases, Ege University School of Medicine, Izmir, Turkey 2 Department of Hematology, Ege University School of Medicine, Izmir, Turkey * This case report was poster presented at ESPID Congress. Abstract Özet Hepatitis A virus (HAV) infection is often asymptomatic or mildly Hepatit A virüs (HAV) enfeksiyonu çocukluk çağında genellikle symptomatic in pediatric population, the severity of the disease asemptomatik ya da hafif seyirlidir, yaş arttıkça hastalığın ciddiyeti artar. increases by age. Immune-mediated extrahepatic extrahepatic Ekstrahepatik immün-aracılı bulgular ve hematolojik komplikasyonlar manifestations and hematologic complications are mainly reported genellikle yetişkinlerde, akut ve kronik hepatit B ve C enfeksiyonlarının in adults with acute and chronic hepatitis B and C. However, they are seyrinde bildirilmiştir. Çocukluk çağında oldukça nadirdir. İngilizce relatively rare in children with HAV infection. There are few available literatürde, çocuklarda hepatit A’nın otoimmün komplikasyonlarını
    [Show full text]
  • Successful Treatment of Canine Malignant Histiocytosis with the Human Major Histocompatibility Complex Nonrestricted Cytotoxic T-Cell Line TALL-1041
    Vol. 3, 1789-1 797. October 1997 Clinical Cancer Research 1789 Successful Treatment of Canine Malignant Histiocytosis with the Human Major Histocompatibility Complex Nonrestricted Cytotoxic T-Cell Line TALL-1041 Sophie Visonneau, Alessandra Cesano, effectors and their therapeutic potential even in the most Thuy Tran, K. Ann Jeglum, and Daniela Santoli2 aggressive forms of the disease. The Wistar Institute, Philadelphia, Pennsylvania 19104 [S. V., A. C.. T. T., D. S.], and Veterinary Oncology Services and Research Center, INTRODUCTION West Chester, Pennsylvania 19382 [K. A. J.] MH3 in dogs, first reported in 1978 ( I ), is a tumor char- actenized by neoplastic proliferation of invasive atypical eryth- nophagocytic histiocytes in various tissues. The disease fre- ABSTRACT quently becomes manifest in the middle-age years and has been The human MHC nonrestricted cytotoxic T-cell line observed more frequently in males than in females (2). Bernese TALL-104 exerts potent antitumor effects in animal models mountain dogs are genetically prone to this type ofcancer (3, 4), with both induced and spontaneous cancers. The present but other breeds are also sporadically affected (5). Clinical report documents the ability of systemically delivered findings commonly include fever, generalized lymphoadenopa- TALL-104 cells to induce durable clinical remissions in four thy, and hepatosplenomegaly as well as concomitant anemia, of four dogs with malignant histiocytosis (MH). The animals leukopenia, and thrombocytopenia (I). Neoplastic histiocytes received multiple i.v injections oflethally irradiated (40 Gy) mainly infiltrate the spleen, liver, lungs, lymph nodes, bone TALL-iN cells at a dose of 108 cells/kg, with (two dogs) or marrow, and skin.
    [Show full text]
  • Langerhans' Cell Histiocytosis Was Made Based on Skin Biopsy of the Abdomen and Needle Biopsy of the Liver, Both Suggestive of LCH
    Langerhans’Caenldl histiocytosis: case reports literature review Robert J. Henry, DDS, MS EdwardA. Sweeney,DMD angerhans’ cell histiocytosis (LCH), formerly logic presence of Langerhans’ granules (also called knownas histiocytosis X, is one of a group of Birbeck’s granules).14 Birbeck’s granules are rod-shaped L poorly understood diseases of histiocytes. The ultrastructural organelles that may have a vesicular clinical spectrum of disease ranges from the chronic, portion giving it a so called "tennis racquet" appearance localized form to an acute leukemia-like disease with a under electron microscopy. 14-16 The presence of fatal outcome.Alfred Handwas the first to report a case Birbeck’ss,17 granules is pathognomonicof LCH. of histiocytosis in 1893.1Later, in 1941, Farber described Although the etiology of LCHhas not been estab- this condition when reporting the overlap amongdis- lished, several theories exist regarding this disease. eases that wouldlater be termed histiocytosis X.2,3 Since Pathologic Langerhans’ cells are thought to be derived that time, numerouscase reports have appeared in the from precursor cells or through alteration of normal dental literature, each having a diverse focus and using histiocytes.16, is The mechanismby whichthis prolifera- inconsistent terminology. The purpose of this review tion and accumulation takes place remains unknown. article is to enhance the understanding of LCHand to Viruses have been implicated as inciting agents in LCH report two cases of very young children demonstrating but their involvementremains theoretical, s, 16 Consider- skull and jaw lesions. able effort has been madeto assess the role of the im- LCHpreviously has been considered a reactive munesystem in the etiology of LCH.The bulk of evi- polyclonal disease of immuneregulation and not a true dence for this theory relates to abnormal thymic neoplasm.
    [Show full text]
  • Monoclonal Antibody (UCHL1) That Recognises Normal and Neoplastic T Cells in Routinely Fixed Tissues
    J Clin Pathol: first published as 10.1136/jcp.39.4.399 on 1 April 1986. Downloaded from J Clin Pathol 1986;39:399-405 Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues AJ NORTON,* AD RAMSAY,* SUSAN H SMITH,t PCL BEVERLEY,t PG ISAACSON* From the *Department ofHistopathology, and the tlmperial Cancer Research Fund, Human Tumour Immunology Group, School ofMedicine, University College, London SUMMARY UCHL1 is a murine monoclonal antibody that recognises a 180-185 kD determinant on CD4 (72%) and CD8 (36%) positive T cells. This antibody is effective in formalin fixed and paraffin embedded tissues, using the immunoperoxidase method. One hundred and forty three cases of malignant lymphoma were examined. Neoplastic cells in 100% of cases of Mycosis fungoides (n = 10), 83% of cases of peripheral T cell lymphoma (n = 25), and 78% of cases of (T-ALL) T acute lymphoblastic lymphoma (n = 9) were stained by this antibody. In addition, staining was seen in 100% of cases of malignant histiocytosis of the intestine (n = 13), a condition now thought to be a T cell lymphoma. Two cases of true histiocytic lymphoma were also positive. This antibody stained neither the neoplastic cells in a wide range of B cell lymphomas (n = 62) nor Reed-Stemnberg cells in 16 cases of Hodgkin's disease. UCHL1 also stained neoplastic cells in four cases of granu- locytic sarcoma. A panel of normal tissues was similarly studied. Staining was seen in normal T cells and mucosal intraepithelial lymphocytes, macrophages, mature myeloid cells, and endometrial stro- mal granulocytes.
    [Show full text]
  • Histiocytic Sarcoma of the Spleen - a Case Report and Review of the Literature
    The Korean Journal of Pathology 2005; 39: 356-9 Histiocytic Sarcoma of the Spleen - A Case Report and Review of the Literature - Jin Ho Paik∙Yoon Kyung Jeon True histiocytic sarcoma is an extremely rare tumor. Its clinicopathological features are not Sung Shin Park1∙Hye Sook Min clearly understood. Here, we report the first Korean case of primary splenic histiocytic sarcoma. Young A Kim2∙Ji Eun Kim2 A 64-year-old female having refractory thrombocytopenia, anemia and splenic mass was admit- Chul Woo Kim ted to the hospital, and received splenectomy. Grossly, spleen was enlarged up to 18×13×8 cm and occupied with multinodular masses. Microscopically, the masses were composed of atyical large cells with abudant cytoplasm and vesicular nuclei with prominent hemophagocy- Department of Pathology, Seoul National University College of Medicine, Seoul; tosis. The tumor cells were CD68 (+), S-100 protein (-), CD21 (-), CD1a (-). After splenecto- 1Department of Pathology, Dongguk my, thrombocytopenia and anemia were corrected. However two months later the symptoms University International Hospital, Goyang; recurred, and the patient died 15 months after splenectomy. This case shared the common 2Department of Pathology, Seoul City clinicopathologic features with the several previously reported cases in other countries, rep- Boramae Hospital, Seoul, Korea resented by splenic mass formation and prominent hemophagocytosis associated with throm- bocytopenia and anemia, often leading to poor outcome. Received : July 27, 2005 Accepted : August 30, 2005 Corresponding Author Chul Woo Kim, M.D. Department of Pathology and Cancer Research Institute, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-799, Korea Tel: 02-740-8275 Fax: 02-743-5530 E-mail: [email protected] Key Words : Histiocytic sarcoma; Spleen; Thrombocytopenia Histiocytic neoplasm is one of the rarest tumors in hematopoi- characteristically accompanied by prominent hemophagocytosis etic and lymphoid system.
    [Show full text]
  • Malignant Histiocytosis (Histiocytic Medullary Reticulosis) with Spindle Cell Differentiation and Tumour Formation
    J Clin Pathol: first published as 10.1136/jcp.30.2.120 on 1 February 1977. Downloaded from J. clin. Path., 1977, 30, 120-125 Malignant histiocytosis (histiocytic medullary reticulosis) with spindle cell differentiation and tumour formation J. B. MACGILLIVRAY1 AND J. S. DUTHIE2 From the Departments ofPathology and Surgery, Maryfield Hospital, Dundee sumMARY Malignant histiocytosis (histiocytic medullary reticulosis) in a 45-year-old white man is described. Unusual features were presentation as a surgical emergency with signs of obstruction and peritonitis due to an ileal tumour and extensive spindle cell differentiation. Problems in the differential diagnosis of malignant histiocytosis are briefly discussed. Malignant histiocytosis has been defined by presentation as a surgical emergency with signs of Rappaport (1966) as a systemic, progressive, obstruction and peritonitis due to a large tumour in invasive proliferation of morphologically atypical the ileum and because the pathology was atypical due histiocytes and of their precursors. The disease, to the prominent spindle cell differentiation in the which is also known as histiocytic medullary ileal tumour, lymph nodes, and bone marrow. reticulosis, was first recognised by Scott and Robb- copyright. Smith (1939). Since then reports of single cases and Case report series of cases have included those by Marshall (1956), Greenberg et al. (1962), Serck-Hanssen and A 45-year-old white man was admitted as a surgical Purchit (1968), Abele and Griffin (1972), Byrne and emergency complaining of severe abdominal pain. Rappaport (1973), and Warnke et al. (1975). For the previous two weeks he had had several Greenberg et at. (1962), who reviewed 47 previously attacks of mild abdominal pain accompanied by reported cases, stressed the repetitious clinical vomiting and he had passed melaena stools.
    [Show full text]
  • Tumors of the Spleen
    TUMORS OF THE SPLEEN These notes are provided to help you understand the diagnosis or possible diagnosis of cancer in your pet. For general information on cancer in pets ask for our handout “What is Cancer”. Your veterinarian may suggest certain tests to help confirm or eliminate diagnosis, and to help assess treatment options and likely outcomes. Because individual situations and responses vary, and because cancers often behave unpredictably, science can only give us a guide. However, information and understanding for tumors in animals is improving all the time. We understand that this can be a very worrying time. We apologize for the need to use some technical language. If you have any questions please do not hesitate to ask us. What is the spleen? The spleen is an organ near the stomach in the abdomen. Its main function is to filter the blood (red pulp), removing worn out blood cells and recycling the proteins and iron. It is also a reserve factory for manufacture of blood cells. In horses and some dogs such as greyhounds, the organ is a reserve for the oxygen-carrying red cells required for sudden bursts of activity. The spleen also contains large numbers of cells of the immune system (lymphocytes and macrophages). These cells are involved in recognizing ‘foreign’ potentially harmful materials like infectious microorganisms and helping the destruction of them and then protection (immunity) against future attack. What type of tumors form in the spleen? Tumors of the spleen are common in older dogs, but rare in cats. Most enlargement of the spleen is not cancerous and due to blood accumulating as a result of poor circulation, often with bleeding within the spleen (hematomas).
    [Show full text]